| 1. |
Martínez-Martínez Má, De Juan Romero C, Fernández V, et al. A restricted period for formation of outer subventricular zone defined by Cdh1 and Trnp1 levels. Nat Commun, 2016, 7: 11812.
|
| 2. |
Corso G, Intra M, Trentin C, et al. CDH1, germline mutations and hereditary lobular breast cancer. Fam Cancer, 2016, 15(2): 215-219.
|
| 3. |
魯發龍, 杜剛毅, 鄭少康, 等. 結直腸癌術中腹腔灌洗液懸浮細胞 CDH1 甲基化檢測及其臨床意義. 中華胃腸外科雜志, 2014, 17(11): 1133-1136.
|
| 4. |
章海波, 馬慶榮, 李智佳, 等. 鈣粘蛋白 E 基因的基因多態性與非小細胞肺癌進展的相關性研究. 中國現代醫學雜志, 2014, 24(13): 18-22.
|
| 5. |
石遠凱, 孫燕, 丁翠敏, 等. 中國埃克替尼治療非小細胞肺癌專家共識(2016 年版). 中國肺癌雜志, 2016, 19(7): 489-494.
|
| 6. |
Turke AB, Zejnullahu K, Wu YL, et al. Pre-existence and clonal selection of MET amplification in EGFR mutant NSCLC. Cancer Cell, 2010, 17(1): 77-88.
|
| 7. |
朱文芳, 李堅, 唐興萍. 非小細胞肺癌患者外周血上皮細胞黏附分子和黏蛋白的診斷價值. 江蘇大學學報(醫學版), 2013, 23(2): 144-148.
|
| 8. |
程波, 武迪, 許琳, 等. 鈣黏附蛋白和連環蛋白在非小細胞肺癌中的表達及意義. 診斷病理學雜志, 2013, 20(11): 685-689.
|
| 9. |
Pannone G, Santoro A, Feola A, et al. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage. Curr Cancer Drug Targets, 2016, 14(2): 115-127.
|
| 10. |
de Lima JM, de Souza LG, da Silva ID, et al. E-cadherin and metalloproteinase-1 and -7 polymorphisms in colorectal cancer. Int J Biol Markers, 2009, 24(2): 99-106.
|
| 11. |
Jin GF, Miao RF, Hu ZB, et al. Putative functional polymorphisms of MMP-9 predict survival of NSCLC in a Chinese population. Int J Cancer, 2009, 124(9): 2172-2178.
|
| 12. |
Wang GH, Tian WJ, Liu YQ, et al. Visfatin triggers the cell motility of non-small cell lung cancer (NSCLC) via up-regulation of matrix metalloproteinases (MMP-s). Basic Clin Pharmacol Toxicol, 2016, 119(6): 548-554.
|